Clinical course and cost assessment of infants with a first episode of acute bronchiolitis presenting to the emergency department: Data from the GUERANDE clinical trial. Issue 12 (13th September 2021)
- Record Type:
- Journal Article
- Title:
- Clinical course and cost assessment of infants with a first episode of acute bronchiolitis presenting to the emergency department: Data from the GUERANDE clinical trial. Issue 12 (13th September 2021)
- Main Title:
- Clinical course and cost assessment of infants with a first episode of acute bronchiolitis presenting to the emergency department: Data from the GUERANDE clinical trial
- Authors:
- Butel, Thibault
Angoulvant, François
Filipovic‐Pierucci, Antoine
Milcent, Karen
Teglas, Jean‐Paul
Bellêttre, Xavier
Claudet, Isabelle
Gras‐le Guen, Christèle
de Pontual, Loïc
Minodier, Philippe
Dubos, François
Brouard, Jacques
Soussan‐Banini, Valérie
Degas‐Bussiere, Vanessa
Gatin, Amélie
Schweitzer, Cyril
Epaud, Ralph
Ryckewaert, Amélie
Cros, Pierrick
Marot, Yves
Flahaut, Philippe
Saunier, Pascal
Babe, Philippe
Patteau, Géraldine
Delebarre, Mathilde
Titomanlio, Luigi
Vrignaud, Bénédicte
Trieu, Thanh‐Van
Tahir, Abdelilah
Regnard, Delphine
Micheau, Pascale
Charara, Oussama
Henry, Simon
Ploin, Dominique
Panjo, Henri
Vabret, Astrid
Bouyer, Jean
Durand‐Zaleski, Isabelle
Gajdos, Vincent
… (more) - Abstract:
- Abstract: Introduction: Bronchiolitis is the leading cause of hospitalization for infants but its economic burden is not well documented . Our objective was to describe the clinical evolution and to assess the 1‐month cost of a first episode of acute bronchiolitis presenting to the emergency department (ED). Methods: Our study was an epidemiologic analysis and a cost study of the cohort drawn from the clinical trial GUERANDE, conducted in 24 French pediatric EDs. Infants of 6 weeks to 12 months of age presenting at pediatric EDs with a first episode of bronchiolitis were eligible. The costs considered were collected from a societal viewpoint, according to the recommendations of the French National Health Authority. Results: A total of 777 infants were included with a median age of 4 months. A total of 57% were hospitalized during the month following the first consultation in the ED, including 28 (3.6%) in an intensive care unit. The mean length of stay was 4.2 days (SD = 3.7). The average time to relief of all symptoms was 13 days (SD = 7). Average total cost per patient was €1919 (95% confidence interval: 1756–2138) from a societal perspective, mostly due to hospitalization cost. The estimated annual cost of bronchiolitis in infants was evaluated to be between €160 and €273 million in France. Discussion: Bronchiolitis represent a high cost for the health care system and broadly for society, with hospitalizations costs being the main cost driver. Thus significant investmentsAbstract: Introduction: Bronchiolitis is the leading cause of hospitalization for infants but its economic burden is not well documented . Our objective was to describe the clinical evolution and to assess the 1‐month cost of a first episode of acute bronchiolitis presenting to the emergency department (ED). Methods: Our study was an epidemiologic analysis and a cost study of the cohort drawn from the clinical trial GUERANDE, conducted in 24 French pediatric EDs. Infants of 6 weeks to 12 months of age presenting at pediatric EDs with a first episode of bronchiolitis were eligible. The costs considered were collected from a societal viewpoint, according to the recommendations of the French National Health Authority. Results: A total of 777 infants were included with a median age of 4 months. A total of 57% were hospitalized during the month following the first consultation in the ED, including 28 (3.6%) in an intensive care unit. The mean length of stay was 4.2 days (SD = 3.7). The average time to relief of all symptoms was 13 days (SD = 7). Average total cost per patient was €1919 (95% confidence interval: 1756–2138) from a societal perspective, mostly due to hospitalization cost. The estimated annual cost of bronchiolitis in infants was evaluated to be between €160 and €273 million in France. Discussion: Bronchiolitis represent a high cost for the health care system and broadly for society, with hospitalizations costs being the main cost driver. Thus significant investments should be made to develop innovative therapies, to reduce the number of hospitalizations and length of stay. … (more)
- Is Part Of:
- Pediatric pulmonology. Volume 56:Issue 12(2021)
- Journal:
- Pediatric pulmonology
- Issue:
- Volume 56:Issue 12(2021)
- Issue Display:
- Volume 56, Issue 12 (2021)
- Year:
- 2021
- Volume:
- 56
- Issue:
- 12
- Issue Sort Value:
- 2021-0056-0012-0000
- Page Start:
- 3802
- Page End:
- 3812
- Publication Date:
- 2021-09-13
- Subjects:
- asthma & early wheeze -- bronchiolitis -- economic evaluation -- epidemiology
Pediatric respiratory diseases -- Periodicals
Pediatrics -- Periodicals
618.922 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-0496 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ppul.25621 ↗
- Languages:
- English
- ISSNs:
- 8755-6863
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6417.605800
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26353.xml